Sign in
Join
Discovery/Preclinical
In vitro
In vivo
Newer Targets
Clinical
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Commercial
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
Contact
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Discovery/Preclinical
All
In vitro
In vivo
Newer Targets
Clinical
Zydus receives approval from COFEPRIS to conduct clinical trials in Mexico…
Clinical
Karyopharm Establishes Partnership with National Cancer Institute to Advance XPOVIO (selinexor)…
Clinical
BeiGene Announces Acceptance of a New Drug Application of Pamiparib in…
Acquisitions
X-Vax Technology Appoints Isaac Blech as Vice Chairman to its Board…
Clinical
All
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Clinical
BeiGene Announces Acceptance of a New Drug Application of Pamiparib in…
Clinical
Karyopharm Establishes Partnership with National Cancer Institute to Advance XPOVIO (selinexor)…
Clinical
Interim Six-Month Data of RPGR Gene Therapy Shows Significant Vision Improvement…
Clinical
Medicine Supply Notification: Ketotifen 1mg/5ml elixir (Zaditen) – FirstWord Pharma
Commercial
All
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Clinical
Sanofi eyes acquisitions in US, including Principia Biopharma: report – FirstWord…
Clinical
Lilly’s mirikizumab superior to Novartis’ Cosentyx in psoriasis study – FirstWord…
Clinical
BeiGene Announces Acceptance of a New Drug Application of Pamiparib in…
Clinical
Karyopharm Establishes Partnership with National Cancer Institute to Advance XPOVIO (selinexor)…
Home
Clinical
Phase III
Phase III
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Phase III
Parliament to allow COVID-19 vaccines to be developed more quickly – FirstWord Pharma
Firstwordpharma News
-
July 10, 2020
Phase III
AMRYT PHARMA PLC: Posting of Annual Report and Notice of Agm London Stock Exchange:AMYT
Phase III
North Sur Resources and Mindset Pharma Announce Proposed Transaction to Accelerate Development of Medical Psychedelics Industry
Phase III
Bristol Myers Squibb Receives Positive CHMP Opinion Recommending Approval of ZEPOSIA (ozanimod) for the Treatment of Adult Patients with Relapsing Remitting Multiple Sclerosis with...
Phase III
Novartis new analysis further shows durable and potent LDL-C reduction with inclisiran, an investigational first-in-class siRNA cholesterol-lowering treatment Swiss Stock Exchange:NOVN
Phase III
Abeona Therapeutics Announces First Patient Treated in Pivotal Phase III Clinical...
Firstwordpharma News
-
March 18, 2020
0
Phase III
Novo Nordisk pauses the clinical trials investigating concizumab (anti-TFPI mAB) in...
Globenewswire News
-
March 16, 2020
0
Phase III
Back to the Drawing Board: MedDay’s MS Therapy Fails in Phase...
Biospace News
-
March 11, 2020
0
Phase III
MedDay’s neurometabolic modulator MD1003 fails Phase III trial in non-active progressive...
Firstwordpharma News
-
March 11, 2020
0
Phase III
AstraZeneca Bladder Cancer Treatment Fails to Hit the Mark in Phase...
Biospace News
-
March 6, 2020
0
1
2
3
...
39
Page 1 of 39
- Advertisement -
MOST POPULAR
Exclusive: AbbVie Continues Philanthropic Giving With $40 Million to Build a...
March 26, 2019
Spotlight: 1st cancer pharmaceutical factory opens in Syria ...
November 21, 2019
MMS Holdings Doubles Growth in South Africa Region Amid Burgeoning Pharmaceutical...
November 20, 2019
Lannett Launches Venlafaxine ER Tablets And Lidocaine Topical Solution 4%
January 6, 2020
Load more
HOT NEWS
Immuno-oncology
Pfizer, Merck KGaA halt Phase III Bavencio study in head and...
Deals
ProQR spins out all Dystrophic Epidermolysis Bullosa activities into newly formed...
Commercial
Dr Gillies O’Bryan-Tear Joins Clarity Pharmaceuticals’ Board
Deals
Personal Genome Diagnostics and Eisai Co., Ltd. Collaborate to Develop Comprehensive...
